(HMTMH) are involved in the "Hannover Transfer Campus" project. LUH is in charge of the project. Partners such as hannoverimpuls, the region and city of Hanover and Gesundheitswirtschaft Hannover e.V. are

ablative therapy). In addition to conducting our own scientific studies, we cooperate with various partners in and outside the Clinical Department. Our working group Dr. med. Patrick Behrendt Hannover Medical

welfare of patients and to the safety of their treatment through the collaboration with our clinical partners. Institute Director Prof. Dr. Ulrike Köhl Assistant Andrea Oppe Feodor-Lynen-Str. 21 D-30625 Hannover

departments at Hannover Medical School and Leibniz University Hannover as well as international partners. The group was established as a junior research group for ‘Myocardial Tissue Engineering’ within [...] project iCARE - Induced pluripotent stem cells for clinically applicable heart repair – with six partner institutions, coordinated by Prof. Dr. U. Martin and Prof. Dr. A. Haverich (LEBAO, HTTG , MHH ).

well as e.g. housing arrangements for families or handicapped. Depending on the profession of the partner, HBRS assists in finding a suitable job. MHH has its own daycare centres, and particular problems [...] school to do one gap year. These pupils will work up to 12 months in MHH research labs as well as partner istitutes. The aim is to attract young people including women as early as possible to pursue a career

important for individual risk assessment and a well-adapted therapy. Our research involves project partners from the MHH (our Department, Department of Pathology, Institute of Biometry, Institute of Medical [...] Services and High Performance Computing (ZIH) in Dresden as well as other, international research partners. Selected publications Greite R , Wang L, Gohlke L, Schott S, Kreimann K, Doricic J , Leffler A [...] graft injury in kidney transplanted patients" 2013-2018 Various projects with different industrial partners Open positions and PhD projects Upon request Contact Gwinner.wilfried(at)mh-hannover.de Greite.

genetically modified product for years before their final distribution and application by our clinical partners. In order to avoid cross-contamination with bacteria or viruses, for example, the patient and donor

giving an example of the current situation. He is responsible for the clinical coordination of all partners in the overall project and for ACRIBiS at the Hannover site and would like to change this unfortunate [...] nationwide project. At MHH, the Peter L. Reichertz Institute for Medical Informatics is the cooperation partner. "Before patient data is collected, we have to create the technical infrastructure for it," says

virologists, to better understand in vivo dynamics of antiviral immunity (see projects and collaboration partners).